Enantiodivergent synthesis of muricatacin related lactones from d-xylose based on the latent symmetry concept: preparation of two novel cytotoxic (+)- and (-)-muricatacin 7-oxa analogs

Tetrahedron

Volumn 62, Issue 48, 2006, Pages 11044-11053

  Popsavin, Velimir ^a   Krstić, Ivana ^a   Popsavin, Mirjana ^a   Srećo, Bojana ^a   Benedeković, Goran ^a   Kojić, Vesna ^b   Bogdanović, Gordana ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

6 O DECYL 2,3 DIDEOXY DEXTRO THREO HEXONO 1,4 LACTONE; 6 O DECYL 2,3 DIDEOXY LEVO THREO HEXONO 1,4 LACTONE; ANTINEOPLASTIC AGENT; DOXORUBICIN; LACTONE DERIVATIVE; UNCLASSIFIED DRUG; XYLOSE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 33750012608     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.09.054     Document Type: Article

References (73)

1. Boger D.L., and Hong J. J. Am. Chem. Soc. 123 (2001) 8515-8519
2. For recent reviews see:
3. Chen S.H. Curr. Med. Chem. 9 (2002) 899-912
4. Gumina G., Song G.Y., and Chu C.K. FEMS Microbiol. Lett. 202 (2001) 9-15
5. Maury G. Antiviral Chem. Chemother. 11 (2000) 165-189
6. Wang P., Hong J.H., Cooperwood J.S., and Chu C.K. Antiviral Res. 40 (1998) 19-44
7. For some recent examples see:
8. Lee S.T., Molyneux R.J., Panter K.E., Chang C.-W.T., Gardner D.R., Pfister J.A., and Garrossian M. J. Nat. Prod. 68 (2005) 681-685
9. Heinrich M.R., Kashman Y., Spiteller P., and Steglich W. Tetrahedron 57 (2001) 9973-9978
10. Vander Jagt D.L., Deck L.M., and Royer R.E. Curr. Med. Chem. 7 (2000) 479-498
11. Umeyama A., Ito S., Yuasa E., Arihara S., and Yamada T. J. Nat. Prod. 61 (1998) 1433-1434
12. Reiser M.J., Kozlowski J.F., Wood K.V., and McLaughlin J.L. Tetrahedron Lett. 32 (1991) 1137-1140
13. Cavé A., Chaboche C., Figadère B., Haramange J.C., Laurens A., Peyrat J.F., Pichon M., Szlosek M., Cotte-Lafitte J., and Quero A.M. Eur. J. Med. Chem. 32 (1997) 617-623
14. Quinn K.J., Isaacs A.K., and Arvary R.A. Org. Lett. 6 (2004) 4143-4145
15. Yoshimitsu T., Makino T., and Nagaoka H. J. Org. Chem. 68 (2003) 7548-7550
16. Rangavan S., and Joseph S.C. Tetrahedron: Asymmetry 14 (2003) 101-105
17. Carda M., Rodriguez S., Gonzalez F., Castillo E., Villanueva A., and Marco J.A. Eur. J. Org. Chem. (2002) 2649-2655
18. Baylon C., Prestat G., Heck M.-P., and Mioskowski C. Tetrahedron Lett. 41 (2000) 3833-3835
19. Couladouros E.A., and Mihou A.P. Tetrahedron Lett. 40 (1999) 4861-4862
20. Solladie G., Hanquet G., Izzo I., and Crumbie R. Tetrahedron Lett. 40 (1999) 3071-3074
21. Szlosek M., Franck X., Figadère B., and Cavé A. J. Org. Chem. 63 (1998) 5169-5172
22. Chang S.-W., Hung C.-Y., Liu H.-H., and Uang B.J. Tetrahedron: Asymmetry 9 (1998) 521-529
23. Quayle P., Rahman S., and Herbert J. Tetrahedron Lett. 36 (1995) 8087-8088
24. van Aar M.P.M., Thijis L., and Zwanenburg B. Tetrahedron 51 (1995) 11223-11234
25. Bonini C., Federici C., Rossi L., and Righi G. J. Org. Chem. 60 (1995) 4803-4812
26. Somfai P. J. Chem. Soc., Perkin Trans. 1 (1995) 817-819
27. Marshall J.A., and Welmaker G.S. J. Org. Chem. 59 (1994) 4122-4125
28. Makabe H., Tanaka A., and Oritani T. Biosci. Biotechnol. Biochem. 57 (1993) 1028-1029
29. Saiah M., Bessodes M., and Antoniakis K. Tetrahedron Lett. 34 (1993) 1597-1598
30. Wang Z.M., Zhang X.L., Sharpless K.B., Sinha S.C., Sinha-Bagchi A., and Keinan E. Tetrahedron Lett. 33 (1992) 6407-6410
31. Tochtermann W., Scholz G., Bunte G., Wolff C., Peters E.M., Peters K., and Von Schnering H.G. Liebigs Ann. Chem. (1992) 1069-1080
32. Marshall J.A., and Welmaker G.S. Synlett (1992) 537-538
33. Figadère B., Haramange J.C., Laurens A., and Cavé A. Tetrahedron Lett. 32 (1991) 7539-7542
34. Scholz G., and Tochtermann W. Tetrahedron Lett. 32 (1991) 5535-5538
35. Dhotare B., and Chattopadhyay A. Tetrahedron Lett. 46 (2005) 3103-3105
36. Chandrasekhar M., Chandra K.L., and Singh V.K. ARKIVOC 7 (2002) 34-45. http://arkat-usa.alfahosting.net/ark/journal/2002/SKessar/SK-387E/387E.asp
37. Chadrasekhar M., Chandra K.L., and Singh V.K. Tetrahedron Lett. 43 (2002) 2773-2775
38. Popsavin V., Grabež S., Popsavin M., and Petrović J. Carbohydr. Lett. 3 (2000) 411-418
39. Yoon S.-H., Moon H.-S., Hwang S.-K., Choi S.R., and Kang S.K. Bioorg. Med. Chem. 6 (1998) 1043-1049
40. Rassu G., Pinna L., Spanu P., Zanardi F., Battistini L., and Casiraghi G. J. Org. Chem. 62 (1997) 4513-4517
41. Gravier-Pelletier C., Saniere M., Charvet I., Le Merrer Y., and Depezay J.-C. Tetrahedron Lett. 35 (1994) 115-118
42. Kang S.K., Cho H.S., Sim H.S., and Kim B.K. J. Carbohydr. Chem. 11 (1992) 807-812
43. Saniere M., Charvet I., Le Merrer Y., and Depezay J.-C. Tetrahedron 51 (1995) 1653-1662
44. Konno H., Hiura N., and Yanaru M. Heterocycles 57 (2002) 1793-1797
45. Andres J.M., de Elena N., Pedrosa R., and Perez-Encabo A. Tetrahedron: Asymmetry 12 (2001) 1503-1509
46. Pichon M., Jullian J.C., Figadère B., and Cavé A. Tetrahedron Lett. 39 (1998) 1755-1758
47. See Ref. 6i.
48. See Ref. 7f;
49. Gypser A., Peterek M., and Scharf H.D. J. Chem. Soc., Perkin Trans. 1 7 (1997) 1013-1016
50. Baussanne I., Schwardt O., Royer J., Pichon M., Figadère B., and Cavé A. Tetrahedron Lett. 38 (1997) 2259-2262
51. See Ref. 6k;
52. See Ref. 6p.
53. Tsai S.H., Hsieh P.C., Wei L.L., Chiu H.F., Wu Y.C., and Wu M.J. Tetrahedron Lett. 40 (1999) 1975-1976
54. Yoon S.H., Moon H.S., and Kang S.K. Bull. Korean Chem. Soc. 19 (1998) 1016-1018
55. See Ref. 7e;
56. See Ref. 5.
57. For a preliminary account of this work see:. Popsavin V., Krstić I., and Popsavin M. Tetrahedron Lett. 44 (2003) 8897-8900
58. For recent accounts on application of the latent symmetry concept in enantioselective syntheses see:
59. Kireev A.S., Breithaupt A.T., Collins W., Nadein O.N., and Kornienko A. J. Org. Chem. 70 (2005) 742-745
60. Ball M., Gaunt M.J., Hook D.F., Jessiman A.S., Kawahara S., Orsini P., Scolaro A., Talbot A.C., Tanner H.R., Yamanoi S., and Ley S.V. Angew. Chem., Int. Ed. 44 (2005) 5433-5438
61. Boulineau F.P., and Wei A. Org. Lett. 6 (2004) 119-121
62. Hudlicky T., Rinner U., Gonzalez D., Akgun H., Schilling S., Siengalewicz P., Martinot T.A., and Pettit G.R. J. Org. Chem. 67 (2002) 8726-8743
63. Hudlicky T. Chem. Rev. 96 (1996) 3-30
64. Popsavin V., Grabež S., Krstić I., Popsavin M., and Djoković D. J. Serb. Chem. Soc. 68 (2003) 795-804
65. Popsavin M., Popsavin V., Vukojević N., and Miljković D. Collect. Czech. Chem. Commun. 59 (1994) 1884-1888
66. Szeja W. Pol. J. Chem. 54 (1980) 1323-1325
67. Popsavin V., Grabež S., Popsavin M., Krstić I., Kojić V., Bogdanović G., and Divjaković V. Tetrahedron Lett. 45 (2004) 9409-9413
68. Prakash K.R.C., and Rao S.P. Tetrahedron 49 (1993) 1505-1510
69. Markidis T., and Kokotos G. J. Org. Chem. 66 (2001) 1919-1923
70. 2 Me).
71. Lee J., Lewin N.E., Acs P., Blumberg P.M., and Marquez V.E. J. Med. Chem. 39 (1996) 4912-4919
72. Although the compound 17 could be stored at -20 °C for weeks without change, it tended to decompose on prolonged standing at room temperature. It should be therefore used in the next synthetic step immediately after its preparation.
73. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., and Boyd M.R. Cancer Res. 48 (1988) 4827-4833